Levodopa ameliorated anorectal constipation in de novo Parkinson's disease: The QL-GAT study.

@article{Tateno2011LevodopaAA,
  title={Levodopa ameliorated anorectal constipation in de novo Parkinson's disease: The QL-GAT study.},
  author={Fuyuki Tateno and Ryuji Sakakibara and Yuko Yokoi and Masahiko Kishi and Emina Ogawa and Tomoyuki Uchiyama and Tatsuya Yamamoto and Tomonori Yamanishi and Osamu Takahashi},
  journal={Parkinsonism & related disorders},
  year={2011},
  volume={17 9},
  pages={
          662-6
        }
}
BACKGROUND Gastrointestinal tract (GIT) dysfunction is common in Parkinson's disease (PD) patients. However, it remains unclear whether levodopa affects GIT function in PD. OBJECTIVE To perform an open study of levodopa's effects on anorectal constipation in de novo PD patients by the quantitative lower-gastrointestinal autonomic test (QL-GAT). METHODS Nineteen unselected de novo PD patients (10 men, 9 women; mean age, 66 years; mean duration of the disease, 2.2 years) were recruited for… CONTINUE READING

Citations

Publications citing this paper.
SHOWING 1-10 OF 18 CITATIONS

Lewy body constipation

  • Journal of the anus, rectum and colon
  • 2019